No products in the cart.
Phase 3 trial fails to demonstrate benefit of semagacestat in Alzheimer’s disease
Image: PD 1. Use of semagacestat was associated with dose-relevant clinical worsening. 2. There were also renal and immunologic effects ...
Tag: LY450139
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.